Delivery of Lnk Protein Inhibits Leukemic Cell Growth
Author Information
Author(s): Looi Chung Yeng, Imanishi Miki, Takaki Satoshi, Sato Miki, Chiba Natsuko, Sasahara Yoji, Futaki Shiroh, Tsuchiya Shigeru, Kumaki Satoru
Primary Institution: Tohoku University School of Medicine
Hypothesis
Can the delivery of wild-type Lnk protein inhibit TPO-induced megakaryoblastic leukemic cell growth?
Conclusion
The delivery of wild-type Lnk R8 fusion protein effectively inhibits TPO-induced growth of leukemic cells by promoting apoptosis.
Supporting Evidence
- WT Lnk R8 significantly inhibited TPO-induced cell growth in M-MOK cells.
- The uptake rate of WT Lnk R8 was over 96% in various cell lines.
- WT Lnk R8 treatment resulted in a significant increase in apoptotic cells compared to controls.
Takeaway
Scientists found a way to deliver a special protein that helps stop cancer cells from growing by making them die.
Methodology
The study used proliferation assays, flow cytometry, and Western blot analyses on leukemic cell lines to evaluate the effects of Lnk protein delivery.
Limitations
The study primarily focused on in vitro results, which may not fully translate to in vivo conditions.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website